Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 3
2010 4
2011 2
2012 3
2013 3
2014 3
2015 1
2016 7
2017 9
2018 9
2019 2
2020 10
2021 14
2022 11
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry.
Jamee M, Azizi G, Baris S, Karakoc-Aydiner E, Ozen A, Kiliç SŞ, Kose H, Chavoshzadeh Z, Mahdaviani SA, Momen T, Shamsian BS, Fallahi M, Sharafian S, Gülez N, Aygun A, Karaca NE, Kutukculer N, Al Sukait N, Al Farsi T, Al-Tamemi S, Khalifa N, Shereen R, El-Ghoneimy D, El-Owaidy R, Radwan N, Alzyoud R, Barbouche MR, Ben-Mustapha I, Mekki N, Rais A, Boukari R, Belbouab R, Djenouhat K, Tahiat A, Touri S, Elghazali G, Al-Hammadi S, Shendi HM, Alkuwaiti A, Belaid B, Djidjik R, Artac H, Adeli M, Sobh A, Elnagdy MH, Bahgat SA, Nasrullayeva G, Chou J, Rezaei N, Al-Herz W, Geha RS, Abolhassani H; MENA-I. E. I. Study Group. Jamee M, et al. Clin Immunol. 2022 Nov;244:109131. doi: 10.1016/j.clim.2022.109131. Epub 2022 Sep 27. Clin Immunol. 2022. PMID: 36179983 Free article.
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Pagliari MT, Budde U, Baronciani L, Eshghi P, Ahmadinejad M, Badiee Z, Baghaipour MR, Benítez Hidalgo O, Biguzzi E, Bodó I, Castaman G, Goudemand J, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Marino R, Oldenburg J, Peake I, Santoro C, Schneppenheim R, Tiede A, Toogeh G, Tosetto A, Trossaert M, Yadegari H, Zetterberg EMK, Mannucci PM, Federici AB, Eikenboom J, Peyvandi F. Pagliari MT, et al. Among authors: eshghi p. J Thromb Haemost. 2023 Apr;21(4):787-799. doi: 10.1016/j.jtha.2023.01.001. Epub 2023 Jan 11. J Thromb Haemost. 2023. PMID: 36792472 Free article.
Factor XIII deficiency in Iran: a comprehensive review of the literature.
Dorgalaleh A, Naderi M, Hosseini MS, Alizadeh S, Hosseini S, Tabibian S, Eshghi P. Dorgalaleh A, et al. Among authors: eshghi p. Semin Thromb Hemost. 2015 Apr;41(3):323-9. doi: 10.1055/s-0034-1395350. Epub 2015 Jan 23. Semin Thromb Hemost. 2015. PMID: 25615432 Review.
Management of COVID-19 Virus Infection by Convalescent Plasma.
Cheraghali AM, Abolghasemi H, Eshghi P. Cheraghali AM, et al. Among authors: eshghi p. Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):3-6. doi: 10.18502/ijaai.v19i(s1.r1).2847. Iran J Allergy Asthma Immunol. 2020. PMID: 32534509 Free article.
Re-positive PCR of SARS-CoV-2 in health care persons during COVID-19 pandemic.
Alebouyeh M, Aavani P, Abdulrahman NA, Haleem AA, Karimi A, Armin S, Fallah F, Amirali A, Sadr S, Ghandchi G, Abdollahi N, Ghanaie RM, Tabatabaei SR, Fahimzad SA, Razmara R, Alzahrani KJ, Khanbabaee G, Vaghefi SS, Imanzadeh F, Eshghi P, Azimi L. Alebouyeh M, et al. Among authors: eshghi p. Cell Mol Biol (Noisy-le-grand). 2022 Feb 4;67(5):138-143. doi: 10.14715/cmb/2021.67.5.19. Cell Mol Biol (Noisy-le-grand). 2022. PMID: 35818260
Clinical and genetic characteristics of hemoglobin H disease in Iran.
Abolghasemi H, Kamfar S, Azarkeivan A, Karimi M, Keikhaei B, Abolghasemi F, Radfar MH, Eshghi P, Alavi S. Abolghasemi H, et al. Among authors: eshghi p. Pediatr Hematol Oncol. 2022 Sep;39(6):489-499. doi: 10.1080/08880018.2021.2017529. Epub 2021 Dec 24. Pediatr Hematol Oncol. 2022. PMID: 34951342
77 results